Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Julia Onken
Predictive MGMT Status in a Homogeneous Cohort of IDH Wildtype Glioblastoma Patients
Acta neuropathologica communications
Forensic Medicine
Molecular Neuroscience
Pathology
Neurology
Cellular
Related publications
The Predictive but Not Prognostic Value of MGMT Promoter Methylation Status in Elderly Glioblastoma Patients: A Meta-Analysis
PLoS ONE
Multidisciplinary
Prognostic Significance of IDH-1 and MGMT in Patients With Glioblastoma: One Step Forward, and One Step Back?
Radiation Oncology
Nuclear Medicine
Radiology
Imaging
Oncology
Personalized Treatment Strategies in Glioblastoma: MGMT Promoter Methylation Status
OncoTargets and Therapy
Oncology
Pharmacology
MGMT Methylation Status: The Advent of Stratified Therapy in Glioblastoma?
Disease Markers
Biochemistry
Medicine
Clinical Biochemistry
Molecular Biology
Genetics
cIMPACT-NOW Update 3: Recommended Diagnostic Criteria for “Diffuse Astrocytic Glioma, IDH-wildtype, With Molecular Features of Glioblastoma, WHO Grade IV”
Acta Neuropathologica
Forensic Medicine
Molecular Neuroscience
Pathology
Neurology
Cellular
A Novel Analytical Model of MGMT Methylation Pyrosequencing Offers Improved Predictive Performance in Patients With Gliomas
Modern Pathology
Forensic Medicine
Pathology
Prognostic Value of MGMT Promoter Methylation in Glioblastoma Patients Treated With Temozolomide-Based Chemoradiation: A Portuguese Multicentre Study
Oncology Reports
Medicine
Cancer Research
Oncology
A Novel Enhancer Regulates MGMT Expression and Promotes Temozolomide Resistance in Glioblastoma
Nature Communications
Astronomy
Genetics
Molecular Biology
Biochemistry
Chemistry
Physics
Clinical Neuropathology Practice Guide 06-2012: MGMT Testing in Elderly Glioblastoma Patients Yes, but How?
Clinical Neuropathology
Medicine
Forensic Medicine
Pathology
Neurology
